GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DV Biomed Co Ltd (ROCO:6539) » Definitions » Change In Receivables

DV Biomed Co (ROCO:6539) Change In Receivables : NT$48.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is DV Biomed Co Change In Receivables?

DV Biomed Co's change in receivables for the quarter that ended in Dec. 2024 was NT$67.6 Mil. It means DV Biomed Co's Accounts Receivable declined by NT$67.6 Mil from Jun. 2024 to Dec. 2024 .

DV Biomed Co's change in receivables for the fiscal year that ended in Dec. 2024 was NT$48.0 Mil. It means DV Biomed Co's Accounts Receivable declined by NT$48.0 Mil from Dec. 2023 to Dec. 2024 .

DV Biomed Co's Accounts Receivable for the quarter that ended in Dec. 2024 was NT$32.8 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. DV Biomed Co's Days Sales Outstanding for the six months ended in Dec. 2024 was 18.40.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. DV Biomed Co's liquidation value for the six months ended in Dec. 2024 was NT$198.2 Mil.


DV Biomed Co Change In Receivables Historical Data

The historical data trend for DV Biomed Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DV Biomed Co Change In Receivables Chart

DV Biomed Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.32 -35.22 50.78 -44.07 48.04

DV Biomed Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30.40 15.72 -59.79 -19.58 67.61

DV Biomed Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$48.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DV Biomed Co  (ROCO:6539) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

DV Biomed Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=32.751/324.861*91
=18.40

2. In Ben Graham's calculation of liquidation value, DV Biomed Co's accounts receivable are only considered to be worth 75% of book value:

DV Biomed Co's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=380.594-243.011+0.75 * 32.751+0.5 * 72.078
=198.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DV Biomed Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of DV Biomed Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


DV Biomed Co Business Description

Traded in Other Exchanges
N/A
Address
Xingai Road, 6th Floor, No.63, Lane 77, Neihu District, Taipei, TWN, 11494
DV Biomed Co Ltd provides medical supplies, skincare, and healthcare products. Its products include Perfectin and L'AMOUR Isis. The company also provides medical materials and needles (medicine), and healthcare products.

DV Biomed Co Headlines

No Headlines